Brief: Galecto Q1 Loss Per Share $0.53

Damora Therapeutics

04/05/2021 14:56

May 4 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO REPORTS FIRST QUARTER FINANCIAL RESULTS AND
PROVIDES A
CORPORATE UPDATE
    * Q1 LOSS PER SHARE $0.53
    * GALECTO, INC. - CASH, CASH EQUIVALENTS, AND INVESTMENTS AS
OF
MARCH 31, 2021 WERE APPROXIMATELY $149 MILLION
    * GALECTO, INC. - CURRENTLY EXPECT THAT CASH, EQUIVALENTS TO
BE
SUFFICIENT TO FUND OPERATING EXPENSES, CAPITAL REQUIREMENTS INTO
2024

Source text for Eikon:  ID:nGNX8S6XB9 
Further company coverage:  GLTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))